BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Dec 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-12-04

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-04	Bio-Rad A Common Stock	M	1250	$159.32	Acquired	2361.7039	Direct
2019-12-04	Bio-Rad A Common Stock	S	1250	$370.11	Disposed	1111.7039	Direct
2019-12-04	Bio-Rad A Common Stock	S	656	$370.12	Disposed	455.7039	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-04	Non-Qualified Stock Option (right to buy)	$159.32	M	1250	Disposed	2026-09-07	Bio-Rad A Common Stock (1250)	Direct

Footnotes

F1: Includes 27.7347 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/19.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.99 to $370.64, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $370.01 to $370.34, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The option vests in five equal annual installments beginning September 7, 2017